BWV Onconetix Inc


$ 3.47 $ -0.40 (-10.55 %)    

Friday, 31-Oct-2025 17:53:57 EDT
QQQ $ 629.16 $ 3.02 (0.48 %)
DIA $ 475.58 $ 0.66 (0.14 %)
SPY $ 681.80 $ 2.23 (0.33 %)
TLT $ 90.21 $ -0.27 (-0.3 %)
GLD $ 368.20 $ -2.01 (-0.54 %)
$ 3.39
$ 3.73
$ 3.30 x 1
$ 3.75 x 10
$ 3.38 - $ 3.73
$ 2.45 - $ 257.99
40,294
na
na
$ 2.39
na
TBD
na
na (na)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 blue-water-biotech-acquires-proteomedix-ag-a-private-commercial-stage-diagnostics-oncology-company-in-stock-consideration-no-terms-disclosed

The acquisition of Proteomedix for all stock consideration provides its shareholders with an initial 19.9% ownership stake of O...

 why-nxu-shares-are-trading-higher-by-around-42-here-are-20-stocks-moving-premarket

Shares of Nxu, Inc. (NASDAQ: NXU) rose sharply in pre-market trading after the company signed a letter of intent outlining inv...

Core News & Articles

https://www.reuters.com/business/healthcare-pharmaceuticals/who-very-worried-about-spread-mpox-drc-2023-12-08/?taid=65734f21df0...

 blue-water-biotech-signed-non-binding-term-sheet-to-acquire-a-commercial-stage-oncology-company

https://www.sec.gov/Archives/edgar/data/1782107/000121390023082344/ea187618ex99-1_bluewater.htm

 stocks-that-hit-52-week-lows-on-tuesday

  Tuesday saw 132 companies set new 52-week lows.

 blue-water-biotech-appoints-dr-neil-j-campbell-as-president-and-ceo-and-bruce-harmon-as-cfo

Blue Water Biotech, Inc. (NASDAQ:BWV), which is focused on developing and commercializing transformational therapies to address...

 stocks-that-hit-52-week-lows-on-tuesday

  On Tuesday, 647 companies set new 52-week lows.

 stocks-that-hit-52-week-lows-on-tuesday

  On Tuesday, 386 stocks made new 52-week lows.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION